FOLH1 and posterior cortical atrophy: In addition to that, recent studies have already suggested that the theoretical improved imaging possible with 18F- compared to 68Ga-labeled PSMA agents may already have an impact on patient care, such as in subjects with biochemically-relapsed PCa 18-20.